Advanced Formulations/Drug Delivery Systems for Subcutaneous Delivery of Protein-Based Biotherapeutics-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Advanced Formulations/Drug Delivery Systems for Subcutaneous Delivery of Protein-Based Biotherapeutics

Published:2022-11 Issue:11 Volume:111 Page:2968-2982
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Lou Hao^ORCID,Feng Mei,Hageman Michael J.

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference200 articles.

1. Challenges and opportunities for the subcutaneous delivery of therapeutic proteins;Turner;J Pharm Sci,2018

2. Improving the outcomes of biopharmaceutical delivery via the subcutaneous route by understanding the chemical, physical and physiological properties of the subcutaneous injection site;Kinnunen;J Controlled Release,2014

3. Subcutaneous delivery of monoclonal antibodies: how do we get there?;Viola;J Controlled Release,2018

4. Anatomical, physiological, and experimental factors affecting the bioavailability of sc-administered large biotherapeutics;Fathallah;J Pharm Sci,2015

5. Mechanistic determinants of biotherapeutics absorption following SC administration;Richter;The AAPS Journal,2012

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanostructure-reinforced multifunctional hydrogels for synergistic cancer therapy;Coordination Chemistry Reviews;2025-01

2. Reversible protein complexes: Advancing subcutaneous delivery with controlled and sustained release of high concentration biologics;Journal of Drug Delivery Science and Technology;2024-10

3. Novel pH‐Responsive Structural Rearrangement of Myristic Acid‐Conjugated Quetiapine Nanosuspension for Enhanced Long‐Acting Delivery Performance;Advanced Science;2024-09-03

4. Stability of Protein Pharmaceuticals: Recent Advances;Pharmaceutical Research;2024-06-27

5. Is it advantageous to use quality by design (QbD) to develop nanoparticle-based dosage forms for parenteral drug administration?;International Journal of Pharmaceutics;2024-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3